Pretransplant evaluation of renal transplant candidates

Seminars in Nephrology

Volumn 22, Issue 6, 2002, Pages 515-525

  Gallon, Lorenzo G ^a   Leventhal, Joseph R ^a   Kaufman, Dixon B ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY SCREENING; BLOOD GROUP ABO INCOMPATIBILITY; CADAVER DONOR; CARDIOVASCULAR DISEASE; FOLLOW UP; HIGH RISK PATIENT; HLA TYPING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIVING DONOR; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; T LYMPHOCYTE; CHRONIC KIDNEY FAILURE; HISTOCOMPATIBILITY TEST; HOSPITAL ADMISSION; IMMUNOLOGY; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; RECURRENT DISEASE; TRANSPLANTATION;

HISTOCOMPATIBILITY TESTING; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIVING DONORS; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; RECURRENCE; TISSUE AND ORGAN PROCUREMENT; WAITING LISTS;

EID: 0036848823     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1053/snep.2002.35966     Document Type: Article

References (72)

1. Evans RW, Manninem DL, Garrison LP, et al: The quality of life of patients with end-stage renal disease. N Engl J Med 312:553-559, 1985
2. Laupacis A, Keown P, Pus N, et al: A study of the quality of life and cost-utility of renal transplantation. Kidney Int 50:235-242, 1996
3. Russell JD, Beecroft ML, Ludwin D, et al: The quality of life in renal transplantation - A prospective study. Transplantation 54:656-660, 1992
4. Wolfe RA, Ashby VB, Milford EL, et al: Comparison of mortality in all patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 341: 1725-1730, 1999
5. Cosio FG, Alamir A, Yim S, et al: Patients survival after renal transplantation. The impact of dialysis pre-transplant. Kidney Int 53:767-770, 1998
6. Ojo A, Wolfe A, Agodoa L, et al: Prognosis after renal transplant failure and the beneficial effects of repeat transplantation: Multivariate analyses from the United States Renal Data System. Transplantation 66:1651-1659, 1998
7. Kumar M, Damask A, Roland M, et al: Kidney transplantation in HIV positive end stage renal disease patients - A prospective study. American Transplant Congress, Washington, DC, 2002, abstr 145
8. Maisonneuve P, Agodoa L, Gellert R, et al: Cancer in patients on dialysis for end-stage renal disease: An international collaborative study. Lancet 354:93-99, 1999
9. Buccianti G, Maisonneuve P, Ravasi B, et al: Cancer among patients on renal replacement therapy: A population-based survey in Lombardy, Italy. Int J Cancer 66:591-593, 1996
10. Penn I: Evaluation of transplant candidate with preexisting malignancies. Ann Transplant 2:14-17, 1997
11. Ojo A, Hanson J, Wolfe R, et al: Long term survival in renal transplant recipients with graft function. Kidney Int 57: 307-313, 2000
12. Manske C, Wang Y, Rector T, et al: Coronary revascularization in insulin-dependent diabetic patients with chronic renal failure. Lancet 340:998-1002, 1992
13. Hiesse C, Buffet C, Neyrat N, et al: Impact of HBV antigenemia on long-term patient survival and cause of death after renal transplantation. Clin Sci 46:461-467, 1992
14. Mathurin P, Mouquet C, Poynard T, et al: Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology 29:257-263, 1999
15. Pol S, Debure A, Degott C, et al: Chronic hepatitis in kidney allograft recipients. Lancet 335:878-880, 1990
16. Rostaing L, Henry S, Cisterne JM, et al: Efficacy and safety of lamivudine on replication of recurrent hepatitis B after cadaveric renal transplantation. Transplantation 64:1624-1627, 1997
17. Jung Y, Lee Y, Yang W, et al: Treatment of chronic hepatitis B with lamivudine in renal transplant recipients. Transplantation 66:733-737, 1998
18. Pereira B, Wright T, Schmid C, et al: The impact of pre-transplantation hepatitis C infection on the outcome of renal transplantation. Transplantation 60:799-805, 1995
19. Cosio F, Sedmak D, Henry M, et al: The high prevalence of severe early posttransplant renal allograft pathology in hepatitis C positive recipients. Transplantation 62:1054-1059, 1996
20. Knoll G, Tankersley M, Lee J, et al: The impact of renal transplantation on survival in hepatitis C-positive end-stage renal disease patients. Am J Kidney Dis 29:608-614, 1997
21. Pereira B, Natov S, Bouthot B, et al: Effects of hepatitis C infection and renal transplantation on survival in end stage renal disease. The New England Organ Bank Hepatitis C Study Group. Kidney Int 53:1374-1381, 1998
22. Rao K, Anderson W, Kasiske B, et al: Value of liver biopsy in the evaluation and management of chronic liver disease in renal transplant recipients. Am J Med 94:241-250, 1993
23. Martin P, Carter D, Fabrizi F, et al: Histopathological features of hepatitis C in renal transplant candidates. Transplantation 69:1479-1484, 2000
24. Koenig P, Vogel W, Umlauft F, et al: Interferon treatment for chronic hepatitis C virus infection in uremic patients. Kidney Int 45:1507-1509, 1994
25. Campistol J, Esforzado N, Martinez J, et al: Efficacy and tolerance of interferon-alpha2b in the treatment of chronic hepatitis C virus infection in haemodialysis patients. Pre and post-renal transplant assessment. Nephrol Dial Transplant 14: 2704-2709, 1999
26. Baid S: Renal thrombotic microangiopathy associated with anticardiolipin antibodies in hepatitis C positive renal allograft recipients. J Am Soc Nephrol 10:146-153, 19990
27. Ducloux D, Pellet E, Fournier V, et al: Prevalence and clinical significance of antiphospholipid antibodies in renal transplant recipients. Transplantation 67:90-93, 1999
28. Morrissey P, Gohh R, Yango A, et al: Anticoagulation Permits Successful Renal Transplantation in Patients with Antiphospholipid Antibody Syndrome. ATC, Washington, DC, 2002, abstr 574
29. Briggs J, Jones E: Recurrence of glomerulonephritis following renal transplantation. Scientific Advisory Board of the ERA-EDTA Registry. European Renal Association-European Dialysis and Transplant Association. Nephrol Dial Transplant 14:564-565, 1999
30. Kasiske B, Cangro C, Hariharan S, et al: The evaluation of renal transplant candidates: Clinical practice guidelines. Am J Transplantation 1:5-95, 2001 (suppl 2)
31. Pinto J, Lacerda G, Cameron J, et al: Recurrence of focal segmental glomerulosclerosis in renal allografts. Transplantation 32:83-89 1981
32. Cheigh J, Mouradian J, Soliman M, et al: Focal segmental glomerulosclerosis in renal transplants. Am J Kidney Dis 2:449-455, 1983
33. Cameron J, Senguttuvan P, Harley B, et al: Focal segmental glomerulosclerosis in fifty-nine renal allografts from a single center, analysis of risk factors for recurrence. Transplant Proc 21:2117-2118, 1989
34. Dantal J, Baatard R, Hourmant M, et al: Recurrent nephrotic syndrome following renal transplantation in patients with focal glomerulosclerosis. A one-center study of plasma exchange effects. Transplantation 52:827-831, 1991
35. Odorico J, Knechtle S, Rayhill S, et al: The influence of native nephrectomy on the incidence of recurrent disease following renal transplantation for primary glomerulonephritis. Transplantation 61:228-234, 1996
36. Stephanian E, Matas A, Mauer S, et al: Recurrence of disease in patients retransplanted for focal segmental glomerulosclerosis. Transplantation 53:755-757, 1992
37. Dall'Amico R, Ghiggeri G, Carraro M, et al: Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children. Am J Kidney Dis 34: 1048-1055, 1999
38. Mowry J, Marik J, Cohen A, et al: Treatment of recurrent focal segmental glomerulosclerosis with high dose cyclosporine A and plasmapheresis. Transplant Proc 25:1345-1346, 1993
39. Saleem M, Ramanan A, Rees L, et al: Recurrent focal segmental glomerulosclerosis in grafts treated with plasma exchange and increased immunosuppression. Pediatr Nephrol 14: 361-364, 2000
40. Iguchi Y, Tanabe K, Yagisawa T, et al: Plasmapheresis for prevention of recurrent focal segmental glomerulosclerosis of kidney allograft in adult recipients. Ther Apher 1:191-194, 1997
41. Odum J, Peh C, Clarkson A, et al: Recurrent mesangial IgA nephritis following renal transplantation. Nephrol Dial Transplant 9:309, 1994
42. Cosyns J, Cochoud C, PouteilNoble C, et al: Recurrence of membranous nephropathy after renal transplantation: Probability, outcome and risk factors. Clin Nephrol 50:144-153, 1998
43. Habid R, Antignac C, Hinglais N, et al: Glomerular lesions in the transplanted kidney in children. Am J Kidney Dis 10:198-202, 1987
44. Andresdottir M, Assmann K, Hoitsma A, et al: Renal transplantation in patients with dense deposit disease: Morphological characteristics of recurrent disease and clinical outcome. Nephrol Dial Transplant 14:1723-1731, 1999
45. Stegall M, Prieto M, Scott L, et al: The Role of Splenectomy and Plasmapheresis in ABO-incompatible Living Donor Kidney Transplantation. ATC, 2002, abstr 557
46. Tanabe K, Tikahashi K, Sonda K, et al: Long-term results of ABO-incompatible living kidney transplantation: A single center experience. Transplantation 65:224-228, 1998
47. Ishikawa A, Itoh M, Ushlyama T, et al: Experience of ABO-incompatible living kidney transplantation after double filtration plasmapheresis. Clin Sci 12:80-83, 1998
48. Takemoto S, Cecka J, Terasaki P: Benefits of HLA-CREG matching for sensitized recipients as illustrated in kidney regrafts. Transplant Proc 29:1417, 1997
49. Stobbe I, Meer-Prins E, de Lange P, et al: Cross-reactive matching does not lead to a better allocation and survival of donor kidneys. Transplantation 70:157-161, 2000
50. Lazda V: Identification of patients at risk for inferior renal allograft outcome by a strongly positive B cell flow cytometry crossmatch. Transplantation 57:964-969, 1994
51. Ghasemian S, Light J, Currier C, et al: The significance of the 1gG anti-B-cell crossmatch on renal transplant outcome. Clin Transplant 11:485-487, 1997
52. Cook D, Fettough H, Gjertson D, et al: Flow cytometry crossmatching FCXM in the UNOS kidney transplant registry, in Cecka J, Terasaki P (eds): Clinical Transplants, Los Angeles, CA, UCLA Tissue Typing Laboratory, 1998, pp 413-419
53. Gebel H, Bray R: Sensitization and sensitivity: Defining the unsensitized patient. Transplantation 66:1370-1374, 2000
54. Gloor J, Moore B, Pineda A, et al: Living Donor Kidney Transplantation in Positive Crossmatch Patients. ATC, Washington, DC, 2002, abstr 142
55. Mategrano V, Thielke J, DeChristopher P, et al: Improved Outcomes After Plasmapheresis of Highly Sensitized Recipients of Renal Allografts. ATC, Washington, DC, 2002, abstr 144
56. U.S. Scientific Registry of Transplant Recipients and the Organ Procurement and Transplantation Network-Transplant Data, 1988-2000. Available: UNOS Web site
57. Hariharan S, Johnson C, Bresnahan B, et al: Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 342:605-612, 2000
58. Najarian J, Gillingham K, Sutherland D, et al: The impact of the quality of initial graft function on cadaver kidney transplants. Transplantation 57:812-816, 1994
59. Azuma H, Nadeau K, Takada M, et al: Cellular and molecular predictors of chronic renal dysfunction after initial ischerma/reperfusion injury of a single kidney. Transplantation 64:1909-197, 1997
60. Lu C, Penfield J, Kielar M, et al: Hypothesis: Is renal allograft rejection initiated by the response to injury sustained during the transplant process? Kidney Int 55:2157-2168, 1999
61. Kaufman DB, Matas AJ, Arrazola L, et al: Transplantation of kidneys from zero-haplotype matched living donors and from distantly related and unrelated donors in the cyclosporine era. Transplant Proc 25:1530, 1993
62. Terasaki P, Cecka J, Gjertson, et al: High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 333:333-336, 1995
63. Najarian J, Chavers B, McHugh L, et al: 20 Years of more of follow-up of living kidney donors. Lancet 340:807-810, 1992
64. Ter Wee P, Tegzess A, Donker A: Renal reserve filtration capacity before and after kidney donation. J Intern Med 228:393-399, 1990
65. Anderson R, Bueschen A, Lloyd L, et al: Short-term and long-term changes in renal function after donor nephrectomy. J Urol 145:11-13, 1991
66. O'Donnell M, Kasiske B, Raij L, et al: Age is a determinant of the glomerular morphologic and functional responses to chronic nephron loss. J Lab Clin Med 106:308-313, 1985
67. Kasiske B, Ma J, Louis T. et al: Long-term effects of reduced renal mass in humans. Kidney Int 48:814-819, 1995
68. Watnick T, Jenkins R, Rackoff P, et al: Microalbuminuria and hypertension in long-term renal donors. Transplantation 45:59-65, 1988
69. Vincenti F, Amend W, Kaysen G, et al: Long-term renal function in kidney donors. Transplantation 36:626-629, 1983
70. Saran R, Marshall S, Madsen R, et al: Long-term follow-up of kidney donors: A longitudinal study. Nephrol Dial Transplant 12:1615-1621, 1997
71. Novick A, Gephardt G, Guz B, et al: Long-term follow-up after partial removal of a solitary kidney. N Engl J Med 325:1058-1062, 1991
72. Flowers J, Jacobs S, Cho E, et al: Comparison of open and laparoscopic live donor nephrectomy. Ann Surg 226:483-490, 1997